Modeling myeloid malignancies using zebrafish

Kathryn S. Potts, Teresa V. Bowman

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Human myeloid malignancies represent a substantial disease burden to individuals, with significant morbidity and death. The genetic underpinnings of disease formation and progression remain incompletely understood. Large-scale human population studies have identified a high frequency of potential driver mutations in spliceosomal and epigenetic regulators that contribute to malignancies, such as myelodysplastic syndromes (MDS) and leukemias. The high conservation of cell types and genes between humans and model organisms permits the investigation of the underlying mechanisms of leukemic development and potential therapeutic testing in genetically pliable pre-clinical systems. Due to the many technical advantages, such as large-scale screening, lineage-tracing studies, tumor transplantation, and high-throughput drug screening approaches, zebrafish is emerging as a model system for myeloid malignancies. In this review, we discuss recent advances in MDS and leukemia using the zebrafish model.

Original languageEnglish (US)
Article number297
JournalFrontiers in Oncology
Volume7
Issue numberDEC
DOIs
StatePublished - Dec 4 2017

Fingerprint

Zebrafish
Myelodysplastic Syndromes
Neoplasms
Leukemia
Preclinical Drug Evaluations
Inborn Genetic Diseases
Epigenomics
Disease Progression
Transplantation
Morbidity
Mutation
Population
Genes
Therapeutics

Keywords

  • Acute myeloid leukemia
  • Hematopoiesis
  • Malignancies
  • Myelodysplastic syndrome
  • Splicing
  • Zebrafish

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Modeling myeloid malignancies using zebrafish. / Potts, Kathryn S.; Bowman, Teresa V.

In: Frontiers in Oncology, Vol. 7, No. DEC, 297, 04.12.2017.

Research output: Contribution to journalReview article

@article{8c622f3c8df64b088c7c536328d8297d,
title = "Modeling myeloid malignancies using zebrafish",
abstract = "Human myeloid malignancies represent a substantial disease burden to individuals, with significant morbidity and death. The genetic underpinnings of disease formation and progression remain incompletely understood. Large-scale human population studies have identified a high frequency of potential driver mutations in spliceosomal and epigenetic regulators that contribute to malignancies, such as myelodysplastic syndromes (MDS) and leukemias. The high conservation of cell types and genes between humans and model organisms permits the investigation of the underlying mechanisms of leukemic development and potential therapeutic testing in genetically pliable pre-clinical systems. Due to the many technical advantages, such as large-scale screening, lineage-tracing studies, tumor transplantation, and high-throughput drug screening approaches, zebrafish is emerging as a model system for myeloid malignancies. In this review, we discuss recent advances in MDS and leukemia using the zebrafish model.",
keywords = "Acute myeloid leukemia, Hematopoiesis, Malignancies, Myelodysplastic syndrome, Splicing, Zebrafish",
author = "Potts, {Kathryn S.} and Bowman, {Teresa V.}",
year = "2017",
month = "12",
day = "4",
doi = "10.3389/fonc.2017.00297",
language = "English (US)",
volume = "7",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",
number = "DEC",

}

TY - JOUR

T1 - Modeling myeloid malignancies using zebrafish

AU - Potts, Kathryn S.

AU - Bowman, Teresa V.

PY - 2017/12/4

Y1 - 2017/12/4

N2 - Human myeloid malignancies represent a substantial disease burden to individuals, with significant morbidity and death. The genetic underpinnings of disease formation and progression remain incompletely understood. Large-scale human population studies have identified a high frequency of potential driver mutations in spliceosomal and epigenetic regulators that contribute to malignancies, such as myelodysplastic syndromes (MDS) and leukemias. The high conservation of cell types and genes between humans and model organisms permits the investigation of the underlying mechanisms of leukemic development and potential therapeutic testing in genetically pliable pre-clinical systems. Due to the many technical advantages, such as large-scale screening, lineage-tracing studies, tumor transplantation, and high-throughput drug screening approaches, zebrafish is emerging as a model system for myeloid malignancies. In this review, we discuss recent advances in MDS and leukemia using the zebrafish model.

AB - Human myeloid malignancies represent a substantial disease burden to individuals, with significant morbidity and death. The genetic underpinnings of disease formation and progression remain incompletely understood. Large-scale human population studies have identified a high frequency of potential driver mutations in spliceosomal and epigenetic regulators that contribute to malignancies, such as myelodysplastic syndromes (MDS) and leukemias. The high conservation of cell types and genes between humans and model organisms permits the investigation of the underlying mechanisms of leukemic development and potential therapeutic testing in genetically pliable pre-clinical systems. Due to the many technical advantages, such as large-scale screening, lineage-tracing studies, tumor transplantation, and high-throughput drug screening approaches, zebrafish is emerging as a model system for myeloid malignancies. In this review, we discuss recent advances in MDS and leukemia using the zebrafish model.

KW - Acute myeloid leukemia

KW - Hematopoiesis

KW - Malignancies

KW - Myelodysplastic syndrome

KW - Splicing

KW - Zebrafish

UR - http://www.scopus.com/inward/record.url?scp=85037038051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037038051&partnerID=8YFLogxK

U2 - 10.3389/fonc.2017.00297

DO - 10.3389/fonc.2017.00297

M3 - Review article

AN - SCOPUS:85037038051

VL - 7

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

IS - DEC

M1 - 297

ER -